EAM Investors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-79,905
| Closed | -$2.57M | – | 393 |
|
|
2023
Q1 | $2.57M | Buy |
+79,905
| New | +$2.57M | 0.51% | 63 |
|
|
2022
Q4 | – | Sell |
-94,413
| Closed | -$2.55M | – | 354 |
|
|
2022
Q3 | $2.55M | Buy |
+94,413
| New | +$2.55M | 0.55% | 57 |
|
|
2020
Q4 | – | Sell |
-42,537
| Closed | -$1.07M | – | 404 |
|
|
2020
Q3 | $1.07M | Buy |
42,537
+10,985
| +35% | +$276K | 0.25% | 187 |
|
|
2020
Q2 | $770K | Sell |
31,552
-53,750
| -63% | -$1.31M | 0.17% | 220 |
|
|
2020
Q1 | $1.26M | Sell |
85,302
-20,127
| -19% | -$298K | 0.39% | 122 |
|
|
2019
Q4 | $1.71M | Buy |
+105,429
| New | +$1.71M | 0.38% | 108 |
|
|
2018
Q2 | – | Sell |
-113,096
| Closed | -$3.48M | – | 364 |
|
|
2018
Q1 | $3.48M | Buy |
113,096
+5,763
| +5% | +$177K | 0.58% | 42 |
|
|
2017
Q4 | $3.84M | Buy |
107,333
+34,815
| +48% | +$1.24M | 0.69% | 21 |
|
|
2017
Q3 | $2M | Buy |
72,518
+38,621
| +114% | +$1.06M | 0.27% | 194 |
|
|
2017
Q2 | $895K | Buy |
+33,897
| New | +$895K | 0.15% | 210 |
|
|
2016
Q1 | – | Sell |
-102,800
| Closed | -$3.51M | – | 353 |
|
|
2015
Q4 | $3.51M | Buy |
+102,800
| New | +$3.51M | 0.46% | 75 |
|
|
2014
Q3 | – | Sell |
-52,668
| Closed | -$1.79M | – | 363 |
|
|
2014
Q2 | $1.79M | Buy |
+52,668
| New | +$1.79M | 0.34% | 86 |
|